Evidence map›Paper›PMID 36644068›Full record

ArticleCureus2022

Tizanidine Toxicity From Ciprofloxacin: A Cautionary Tale.

Lokesh Goyal, Deobrat Mallick, Miana R Zapata, Kanica Yashi, Prabal Chourasia, Salim Surani

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Lokesh GoyalHospital Medicine, Christus Spohn Hospital Corpus Christi - Shoreline, Corpus Christi, USA.
Deobrat MallickInternal Medicine, Christus Spohn Hospital Corpus Christi - Shoreline, Corpus Christi, USA.
Miana R ZapataInternal Medicine, University of the Incarnate Word School of Osteopathic Medicine, San Antonio, USA.
Kanica YashiInternal Medicine, Bassett Health Care, Cooperstown, USA.
Prabal ChourasiaHospital Medicine, Mary Washington Hospital, Fredericksburg, USA.
Salim SuraniAnesthesiology, Mayo Clinic, Rochester, USA.
University of the Incarnate Word · USBassett Healthcare Network · USMayo Clinic in Florida · USTexas College · USUniversity of North Texas at Dallas · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tizanidine is an alpha-2 adrenergic agonist used commonly by medical professionals to treat patients' chronic spasticity, muscle spasms, and neuralgia usually associated with myofascial components. This medication is also used very frequently in detoxification centers on patients treated for analgesic withdrawal, especially those who are suffering from rebound headaches due to the discontinuation of analgesics. Tizanidine is metabolized in the human body by the cytochrome P450 CYP1A2. On the other hand, ciprofloxacin is a common antibiotic belonging to the class of fluoroquinolones and is used to treat various infections. Ciprofloxacin inhibits the bacterial DNA-gyrase enzyme resulting in the destruction of the organism. Ciprofloxacin is also an inhibitor of the cytochrome P450 CYP1A2. Even though these two medications show obvious interaction still, however, both these medications are often prescribed together, and their interactions/contraindications are often overlooked by many physicians and other providers. We hereby describe the case report of the interaction between tizanidine and ciprofloxacin, along with the adverse outcome related to the concomitant use of these two drugs.

Indexed as

alpha-2 adrenergic agonistciprofloxacincyp1a2cytochrome p450 cyp1a2hypotensionmuscle spasticityp450tizanidine

Identifiers

PMID36644068
PMCPMC9836827
OpenAlexW4311301111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.